Lilly says that the FDA wants to look closer at efficacy implications of the Pha...
Different therapeutic approaches against antibiotic-resistant bacteria were high...
Nouscom is part of a cancer vaccine landscape that has recently jump-started fol...
The Phase III KEYLYNK-006 study evaluating a Keytruda/Lynparza combination treat...
Deals involving research into molecular glues have skyrocketed this year as big ...
In addition to drug discovery deals, NVIDIA also announced partnerships with J&J...
Eli Lilly's LillyDirect allows for online consultations and prescriptions, and A...
Asieris presented positive Phase III results at the 2024 Society of Gynecologic ...
As AstraZeneca looks to move past chemotherapy and radiotherapy, it will enter a...
The China NMPA has granted approval to KeChow Pharma's tunlametinib for treating...
Microsoft has announced plans to broaden its partnership with NVIDIA to leverage...
Bristol Myers Squibb (BMS) has concluded the acquisition of Karuna Therapeutics ...
TB is the leading determiner of death in patients with HIV, yet while new drug r...
The new initiative aims to spur innovation and mobilisation of sectors to drive ...
Madrigal’s Rezdiffra received an accelerated approval as a treatment for noncirr...
